年轻IPMN患者胰腺切除术后长期生活质量良好
该研究分析了2004至2020年间50岁及以下因导管内乳头状黏液性肿瘤(IPMN)接受胰腺切除的78例患者,随访中位95个月,56例(72%)获得长期随访。患者长期生活质量优异,QLQ-C30总体健康状况71.1%、功能评分82.9%、症状负担16.8%,与同龄德国一般人群相近;63%需胰酶替代、16%患胰岛素依赖糖尿病。结论支持在临床有指征时对年轻IPMN患者行手术治疗。
要点
- 年轻IPMN患者术后长期生活质量高,接近同龄一般人群
- 随访时63%需胰酶替代、16%存在胰岛素依赖糖尿病
- 保留胰腺实质的切除方式与更佳结局相关
核心结论
- 年轻患者因IPMN行胰腺切除后长期生活质量很高,与一般人群相当,尽管可能存在外分泌或内分泌功能不全。
- 研究结果支持在临床有指征时对年轻IPMN患者行手术治疗,并提示其预期寿命长、健康状态良好。
研究设计与样本
- 回顾性分析2004至2020年间因IPMN接受手术患者的围术期与长期随访数据。
- 共78例50岁及以下患者接受IPMN切除,中位随访95个月,56例(72%)有长期随访资料。
- 生活质量采用欧洲癌症研究与治疗组织QLQ-C30和QLQ-PAN26问卷评估。
主要发现
- 有随访资料患者手术时中位年龄46岁。
- 初始术式包括胰十二指肠切除30例(54%)、远端胰腺切除8例(14%)、全胰腺切除4例(7%)、剜除13例(23%)、中段切除1例(2%)。
- 最终病理证实IPMN相关癌4例(7%)、高级别IPMN 14例(25%)、低级别IPMN 38例(68%)。
- 评估时35例(63%)需胰酶替代,9例(16%)患胰岛素依赖糖尿病,其中5例在全胰腺切除后。
- QLQ-C30总体健康状况71.1%、功能评分82.9%、症状负担16.8%;QLQ-PAN26总体症状评分20.7%,最常见症状为乏力、失眠和腹泻。
关键数值与推荐
- QLQ-C30总体健康状况71.1%,功能评分82.9%,症状负担16.8%。
- QLQ-PAN26总体症状评分20.7%,最常见症状为乏力、失眠、腹泻。
- 生活质量评分与年龄匹配的德国一般人群接近,保留胰腺实质的切除与特别有利的结局相关。
临床怎么用
- 对年轻IPMN患者在临床有指征时可积极考虑手术,术后长期生活质量预期良好。
- 术前应向年轻患者说明术后胰酶替代和糖尿病风险,尤其是全胰腺切除者。
- 在肿瘤学安全前提下优先考虑保留胰腺实质的术式以改善长期结局。
局限性
- 长期随访资料仅覆盖56例(72%),存在失访。
- 为单中心回顾性研究,样本量78例,结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraductal papillary mucinous neoplasms are increasingly detected in younger patients, but data on long-term outcomes after pancreatic resection in this age group remain limited. The potential burden of postoperative morbidity and its impact on health-related quality of life have raised concerns and often temper confidence in early surgical intervention. This study investigated long-term quality of life and functional outcomes in patients ages 50 years or younger who underwent resection for intraductal papillary mucinous neoplasms. METHODS: Perioperative and long-term follow-up data of patients who had undergone surgery for intraductal papillary mucinous neoplasms between 2004 and 2020 were analyzed. Quality of life was assessed using the European Organisation for Research and Treatment of Cancer quality-of life-questionnaires QLQ-C30 and QLQ-PAN26. RESULTS: A total of 78 patients ages 50 years or younger underwent resection for intraductal papillary mucinous neoplasms. Median follow-up was 95 months, with long-term follow-up available in 56 patients (72%). Among the patients with available follow-up, the median age at the time of surgery was 46 years. The initial surgical procedures included pancreaticoduodenectomy in 30 patients (54%), distal pancreatectomy in 8 patients (14%), total pancreatectomy in 4 patients (7%), enucleation in 13 patients (23%), and middle segment resection in 1 patient (2%). Final histology confirmed intraductal papillary mucinous neoplasm-associated carcinoma in 4 patients (7%), high-grade intraductal papillary mucinous neoplasm in 14 patients (25%), and low-grade intraductal papillary mucinous neoplasm in 38 patients (68%). At the time of assessment, 35 patients (63%) required pancreatic enzyme substitution, and 9 patients (16%) had insulin-dependent diabetes mellitus, 5 of whom after total pancreatectomy. Patients reported excellent long-term quality of life. QLQ-C30 demonstrated a global health status of 71.1%, with high functioning scores (82.9%) and low symptom burden (16.8%). QLQ-PAN26 revealed an overall symptom score of 20.7%, with fatigue, insomnia, and diarrhea as the most common symptoms. For reference, quality-of-life scores closely matched those of the age-matched general German population, and parenchyma-sparing resections were associated with particularly favorable outcomes. CONCLUSION: Young patients undergoing pancreatic resection for intraductal papillary mucinous neoplasms achieve remarkably high long-term quality of life, comparable to the general population, despite potential exocrine or endocrine insufficiency. These findings support surgical management in young patients with IPMNs when clinically indicated and underscore a long life expectancy with a high level of well-being.
引用
- Rompen IF, Marstaller-Walz K, Hinz U, et al. Long-term quality of life after surgery for intraductal papillary mucinous neoplasms in young patients. Surgery. 2026. PMID: 42114236. doi:10.1016/j.surg.2026.110216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。